VistaGen Therapeutics, Inc. (VSTA): Human Clinical Trials in a Test Tube™ to Curb Cost and Time to Market
VistaGen Therapeutics, a California-based biotechnology company, is addressing the need to bring effective treatments to market while reducing the time and cost traditionally needed to do so. By leveraging its Human Clinical Trials in a Test Tube™, the company is using human pluripotent stem cell technology to enable biotechnology and pharmaceutical companies to identify unexpected heart or liver safety concerns before a drug candidate has journeyed far into its development process. With this “drug rescue” capability, biotechnology and pharmaceutical companies also become able to renew their approval efforts of once promising, but currently idle drug candidates that were discontinued due…